🇺🇸 FDA
Pipeline program

dexmedetomidine

C0801039

Approved small_molecule completed

Quick answer

dexmedetomidine for MRI Sedation is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
MRI Sedation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials